Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostate cancer reactivates developmental epigenomic programs during metastatic progression
Mark M. Pomerantz, Xintao Qiu, Yanyun Zhu, et al.
Nature Genetics (2020) Vol. 52, Iss. 8, pp. 790-799
Open Access | Times Cited: 231

Showing 1-25 of 231 citing articles:

Developmental cell programs are co-opted in inflammatory skin disease
Gary Reynolds, Péter Végh, James Fletcher, et al.
Science (2021) Vol. 371, Iss. 6527
Open Access | Times Cited: 379
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart, et al.
Nature Cancer (2021) Vol. 2, Iss. 4, pp. 444-456
Open Access | Times Cited: 173
The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives
Jamal Majidpoor, Keywan Mortezaee
Clinical Immunology (2021) Vol. 226, pp. 108707-108707
Closed Access | Times Cited: 172
Landscape of allele-specific transcription factor binding in the human genome
Sergey Abramov, Alexandr Boytsov, Daria Bykova, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 140
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Yundong He, Weidong Xu, Yu‐Tian Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 125
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer
Alastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 9, pp. 1023-1034
Open Access | Times Cited: 116
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
Xintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 96
Complexities of Prostate Cancer
Sobia Wasim, Sang‐Yoon Lee, Jaehong Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14257-14257
Open Access | Times Cited: 86
The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation
Jef Haerinck, Steven Goossens, Geert Berx
Nature Reviews Genetics (2023) Vol. 24, Iss. 9, pp. 590-609
Closed Access | Times Cited: 68
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
Martin Bakht, Yasutaka Yamada, Sheng‐Yu Ku, et al.
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 699-715
Open Access | Times Cited: 64
Liquid biopsy epigenomic profiling for cancer subtyping
Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2737-2741
Open Access | Times Cited: 50
Pioneer of prostate cancer: past, present and the future of FOXA1
Mona Teng, Stanley Zhou, Changmeng Cai, et al.
Protein & Cell (2020) Vol. 12, Iss. 1, pp. 29-38
Open Access | Times Cited: 121
Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers
Mark A. Rubin, Robert G. Bristow, Phillip Thienger, et al.
Molecular Cell (2020) Vol. 80, Iss. 4, pp. 562-577
Open Access | Times Cited: 102
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma
Biniam Adane, Gabriela Alexe, Bo Kyung A. Seong, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 827-844.e10
Open Access | Times Cited: 89
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer
Xiaodong Lü, Ka-wing Fong, Galina Gritsina, et al.
Nature Genetics (2022) Vol. 54, Iss. 5, pp. 670-683
Open Access | Times Cited: 69
FOXA1 overexpression suppresses interferon signaling and immune response in cancer
Yundong He, Liguo Wang, Ting Wei, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 14
Open Access | Times Cited: 65
Mapping genomic and epigenomic evolution in cancer ecosystems
Toshikazu Ushijima, Susan J. Clark, Patrick Tan
Science (2021) Vol. 373, Iss. 6562, pp. 1474-1479
Closed Access | Times Cited: 64
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
Marco Bolis, Daniela Bossi, Arianna Vallerga, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Androgen receptor and MYC equilibration centralizes on developmental super-enhancer
Haiyang Guo, Yiming Wu, Mannan Nouri, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Dae‐Hwan Kim, Duanchen Sun, William K. Storck, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 17, pp. 4923-4936
Open Access | Times Cited: 56
The roles of epigenetics in cancer progression and metastasis
Jocelyn F. Chen, Qin Yan
Biochemical Journal (2021) Vol. 478, Iss. 17, pp. 3373-3393
Open Access | Times Cited: 56
Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
Simon Linder, Marlous Hoogstraat, Suzan Stelloo, et al.
Cancer Discovery (2022) Vol. 12, Iss. 9, pp. 2074-2097
Open Access | Times Cited: 52
Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis
Hyun Ho Han, Yan Wang, Josué Curto, et al.
Cell Reports (2022) Vol. 39, Iss. 1, pp. 110595-110595
Open Access | Times Cited: 44
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G. Zhao, Samuel Levy, et al.
Cancer Research (2022) Vol. 82, Iss. 21, pp. 3888-3902
Open Access | Times Cited: 44
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer
Erolcan Sayar, Radhika A. Patel, Ilsa M. Coleman, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top